The invention relates to the use of an agent having, stimulating or maintaining tumor necrosis factor (TNF) activity, together with an interferon (IFN) for treating and/or preventing demyelinating diseases, in particular multiple sclerosis (MS). The use of a combination of a TNF or a tumor necrosis factor binding protein in combination with an interferon for treating and/or preventing demyelinating diseases is preferred.

 
Web www.patentalert.com

< Polymer coating of cells

> Breast cancer cell lines and uses thereof

> Methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers

~ 00586